• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于口服蛋白质递送的N-三甲基壳聚糖纳米颗粒的体外和体内研究。

In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.

作者信息

Chen Fu, Zhang Zhi-Rong, Yuan Fang, Qin Xuan, Wang Minting, Huang Yuan

机构信息

Key Laboratory of Drug Targeting of Ministry of Education, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, PR China.

出版信息

Int J Pharm. 2008 Feb 12;349(1-2):226-33. doi: 10.1016/j.ijpharm.2007.07.035. Epub 2007 Aug 2.

DOI:10.1016/j.ijpharm.2007.07.035
PMID:17825506
Abstract

In this study, the effects of alginate modification on absorption properties of FITC-BSA loaded TMC nanoparticles were investigated on an in vitro model of GI epithelium (Caco-2 cells). The feasibility of applying TMC nanoparticles loaded with a model vaccine urease in oral vaccination was also studied. Alginate modified TMC nanoparticles showed higher FITC-BSA permeate efficiency than non-modified TMC nanoparticles. However, alginate modification barely had any effect on TMC nanoparticles' property of decreasing TEER or enhancing drug paracellular transport. Mice s.c. immunized with urease loaded TMC nanoparticles showed highest systematic immune response (IgG levels) but the lowest mucosal response (secretory IgA levels). In the contrast, mice i.g. immunized with urease loaded TMC nanoparticles showed much higher antibody titers of both IgG and secretory IgA than those with urease solution or urease co-administrated with TMC solution. These results indicated that TMC nanoparticles are potential carriers for oral protein and vaccine delivery.

摘要

在本研究中,在胃肠道上皮细胞(Caco-2细胞)的体外模型上研究了海藻酸盐修饰对负载异硫氰酸荧光素标记牛血清白蛋白(FITC-BSA)的三聚氰胺甲醛共聚物(TMC)纳米颗粒吸收特性的影响。还研究了口服接种负载模型疫苗脲酶的TMC纳米颗粒的可行性。海藻酸盐修饰的TMC纳米颗粒比未修饰的TMC纳米颗粒表现出更高的FITC-BSA渗透效率。然而,海藻酸盐修饰对TMC纳米颗粒降低跨上皮电阻(TEER)或增强药物细胞旁转运的特性几乎没有任何影响。皮下注射负载脲酶的TMC纳米颗粒免疫的小鼠表现出最高的全身免疫反应(IgG水平),但黏膜反应最低(分泌型IgA水平)。相比之下,口服接种负载脲酶的TMC纳米颗粒免疫的小鼠,其IgG和分泌型IgA的抗体滴度均远高于接种脲酶溶液或脲酶与TMC溶液共同给药的小鼠。这些结果表明,TMC纳米颗粒是口服蛋白质和疫苗递送的潜在载体。

相似文献

1
In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.用于口服蛋白质递送的N-三甲基壳聚糖纳米颗粒的体外和体内研究。
Int J Pharm. 2008 Feb 12;349(1-2):226-33. doi: 10.1016/j.ijpharm.2007.07.035. Epub 2007 Aug 2.
2
Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.用于非侵入性疫苗递送的单-N-羧甲基壳聚糖(MCC)和N-三甲基壳聚糖(TMC)纳米颗粒。
Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9.
3
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.黏膜免疫中可生物降解纳米颗粒佐剂效应的作用机制研究。
J Control Release. 2009 Sep 1;138(2):113-21. doi: 10.1016/j.jconrel.2009.05.011. Epub 2009 May 13.
4
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.负载流感亚单位抗原的N-三甲基壳聚糖(TMC)纳米颗粒用于鼻内接种疫苗:小鼠模型中的生物学特性和免疫原性
Vaccine. 2007 Jan 2;25(1):144-53. doi: 10.1016/j.vaccine.2006.06.086. Epub 2006 Aug 4.
5
Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.作为蛋白质载体的氯化N-三甲基壳聚糖纳米颗粒的评估与改性
Int J Pharm. 2007 May 4;336(1):166-73. doi: 10.1016/j.ijpharm.2006.11.027. Epub 2006 Nov 12.
6
TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.TMC-MCC(三甲基壳聚糖-单-N-羧甲基壳聚糖)纳米复合物用于疫苗的黏膜传递。
Eur J Pharm Sci. 2009 Nov 5;38(4):362-9. doi: 10.1016/j.ejps.2009.08.010. Epub 2009 Sep 4.
7
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.鼻腔接种用 N-三甲基壳聚糖和 PLGA 基纳米粒:纳米粒特性决定了包封抗原在小鼠体内的抗体应答的质量和强度。
Vaccine. 2010 Aug 31;28(38):6282-91. doi: 10.1016/j.vaccine.2010.06.121. Epub 2010 Jul 16.
8
Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.叶酸偶联 N-三甲基壳聚糖纳米粒作为蛋白载体靶向叶酸受体的制备及表征:体外研究。
J Drug Target. 2009 May;17(4):294-303. doi: 10.1080/10611860902737920.
9
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.负载蛋白质的N-三甲基壳聚糖纳米粒作为鼻腔给药系统的制备与表征
J Control Release. 2006 Mar 10;111(1-2):107-16. doi: 10.1016/j.jconrel.2005.11.014. Epub 2005 Dec 27.
10
Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.载抗神经兴奋肽(ANEP)的 N-三甲基壳聚糖季铵盐纳米粒的制备及脑靶向评价。
Int J Pharm. 2010 Feb 15;386(1-2):249-55. doi: 10.1016/j.ijpharm.2009.11.002. Epub 2009 Nov 10.

引用本文的文献

1
Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances.口服肽和蛋白质疗法给药的障碍与策略:临床进展最新情况
Pharmaceutics. 2025 Mar 21;17(4):397. doi: 10.3390/pharmaceutics17040397.
2
Current Advancements on Oral Protein and Peptide Drug Delivery Approaches to Bioavailability: Extensive Review on Patents.口服蛋白和肽类药物传递方法生物利用度的最新进展:专利广泛综述。
Recent Adv Drug Deliv Formul. 2024;18(4):227-246. doi: 10.2174/0126673878299775240719061653.
3
Exploring the antimicrobial potential of chitosan nanoparticles: synthesis, characterization and impact on virulence factors.
探索壳聚糖纳米颗粒的抗菌潜力:合成、表征及其对毒力因子的影响。
Nanoscale Adv. 2024 Apr 22;6(12):3093-3105. doi: 10.1039/d4na00064a. eCollection 2024 Jun 11.
4
Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery.用于潜在鼻脑递送的聚己内酯-艾地苯醌纳米颗粒的合成与表征
Biomedicines. 2023 May 22;11(5):1491. doi: 10.3390/biomedicines11051491.
5
Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives.新型壳聚糖衍生物的口服给药途径研究
Polymers (Basel). 2022 May 24;14(11):2131. doi: 10.3390/polym14112131.
6
Biomedical polymers: synthesis, properties, and applications.生物医学聚合物:合成、性质及应用
Sci China Chem. 2022;65(6):1010-1075. doi: 10.1007/s11426-022-1243-5. Epub 2022 Apr 24.
7
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives.蛋白质和肽的口服递送:挑战、现状与未来展望。
Acta Pharm Sin B. 2021 Aug;11(8):2416-2448. doi: 10.1016/j.apsb.2021.04.001. Epub 2021 Apr 29.
8
Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability.具有P-糖蛋白抑制作用的药物制剂作为增强口服药物吸收和生物利用度的有前景方法。
Pharmaceutics. 2021 Jul 20;13(7):1103. doi: 10.3390/pharmaceutics13071103.
9
Demystifying particle-based oral vaccines.解析基于粒子的口服疫苗。
Expert Opin Drug Deliv. 2021 Oct;18(10):1455-1472. doi: 10.1080/17425247.2021.1946511. Epub 2021 Jul 6.
10
Immunogenicity of glycine nanoparticles containing a chimeric antigen as vaccine candidate.含有嵌合抗原的甘氨酸纳米颗粒作为候选疫苗的免疫原性。
Clin Exp Vaccine Res. 2021 Jan;10(1):35-43. doi: 10.7774/cevr.2021.10.1.35. Epub 2021 Jan 31.